Sean A. Freeman
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
No association between the wearing-off effect and α4-integrin receptor saturation in natalizumab treated patients with relapsing-remitting multiple sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 12, 2025
Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 19, 2025
Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: October 15, 2024
Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms.
Journal: Journal of neuroimmunology
Published: March 29, 2024
Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 22, 2023
Reverse triggering with breath stacking in ARDS patients: the "optimum" can be the enemy of the "good".
Journal: Minerva anestesiologica
Published: February 23, 2018
Mechanisms of sodium channel clustering and its influence on axonal impulse conduction.
Journal: Cellular and molecular life sciences : CMLS
Published: September 15, 2015
Acceleration of conduction velocity linked to clustering of nodal components precedes myelination.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 07, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026